Howard Streicher1. 1. Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, National Cancer Institute, National Institutes of Health, MD, USA.
Authors: Diego Chowell; Luc G T Morris; Claud M Grigg; Jeffrey K Weber; Robert M Samstein; Vladimir Makarov; Fengshen Kuo; Sviatoslav M Kendall; David Requena; Nadeem Riaz; Benjamin Greenbaum; James Carroll; Edward Garon; David M Hyman; Ahmet Zehir; David Solit; Michael Berger; Ruhong Zhou; Naiyer A Rizvi; Timothy A Chan Journal: Science Date: 2017-12-07 Impact factor: 47.728
Authors: Edward A Stadtmauer; Joseph A Fraietta; Simon F Lacey; Carl H June; Megan M Davis; Adam D Cohen; Kristy L Weber; Eric Lancaster; Patricia A Mangan; Irina Kulikovskaya; Minnal Gupta; Fang Chen; Lifeng Tian; Vanessa E Gonzalez; Jun Xu; In-Young Jung; J Joseph Melenhorst; Gabriela Plesa; Joanne Shea; Tina Matlawski; Amanda Cervini; Avery L Gaymon; Stephanie Desjardins; Anne Lamontagne; January Salas-Mckee; Andrew Fesnak; Donald L Siegel; Bruce L Levine; Julie K Jadlowsky; Regina M Young; Anne Chew; Wei-Ting Hwang; Elizabeth O Hexner; Beatriz M Carreno; Christopher L Nobles; Frederic D Bushman; Kevin R Parker; Yanyan Qi; Ansuman T Satpathy; Howard Y Chang; Yangbing Zhao Journal: Science Date: 2020-02-06 Impact factor: 47.728
Authors: Diego Chowell; Chirag Krishna; Federica Pierini; Vladimir Makarov; Naiyer A Rizvi; Fengshen Kuo; Luc G T Morris; Nadeem Riaz; Tobias L Lenz; Timothy A Chan Journal: Nat Med Date: 2019-11-07 Impact factor: 53.440